Literature DB >> 31768767

High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.

Hai-Bo Hu1, Xiao-Ping Yang1, Pei-Xia Zhou1, Xin-Ai Yang1, Bin Yin2.   

Abstract

BACKGROUND: Lung adenocarcinoma (LUAD) is a more frequent subtype of lung cancer and most cases are discovered in the late stages. The proliferation and metastasis of LUAD are pivotal for disease progression. Despite unremitting deeper understanding of LUAD biology, the mechanisms involved in the proliferation and metastasis of LUAD remain unclear. The objective of our article was to inquiry the expression and the function of keratin 6C (KRT6C) in LUAD cells.
METHODS: First, the expression level and prognostic value of KRT6C in LUAD tissues were analyzed on the basis of the data acquired from TCGA database. Through qRT-PCR, the expression level of KRT6C on LUAD cell lines (A549, H1299, PC-9) and human normal lung cell line MRC-5 was tested. After that, CCK8 and colony formation assays was utilized to detect cell proliferation. In addition, to explore the influence of KRT6C on LUAD migration and invasion ability, scratch wound healing and transwell assays were utilized. Through western blotting, the protein expression levels of KRT6C, PCNA, E-cadherin, N-cadherin, Snail and Vimentin were detected.
RESULTS: The outcomes revealed that KRT6C was highly expressed in LUAD tissues and cell lines. Besides, elevated level of KRT6C was related to worse prognosis in LUAD patients. Ablation of KRT6C restrained proliferation, migration and invasion of A549 cells. KRT6C deficiency augmented the expression of E-cadherin as well as reduced the expression of N-cadherin, Snail and Vimentin.
CONCLUSION: Above all, these consequences indicated that depletion of KRT6C suppressed A549 cell proliferation, migration and invasion, which might be achieved by regulating EMT. In general, KRT6C is identified as a potential therapeutic target for LUAD.

Entities:  

Keywords:  A549; Epithelial–mesenchymal transition; Invasion; Keratin 6C; Lung adenocarcinoma; Migration; Proliferation

Mesh:

Substances:

Year:  2019        PMID: 31768767     DOI: 10.1007/s13258-019-00889-5

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   1.839


  35 in total

1.  Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics.

Authors:  Laura M López-Sánchez; Bernabé Jurado-Gámez; Nuria Feu-Collado; Araceli Valverde; Amanda Cañas; José L Fernández-Rueda; Enrique Aranda; Antonio Rodríguez-Ariza
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-06-15       Impact factor: 5.464

2.  Keratin 23 Is a Peroxisome Proliferator-Activated Receptor Alpha-Dependent, MYC-Amplified Oncogene That Promotes Hepatocyte Proliferation.

Authors:  Donghwan Kim; Chad N Brocker; Shogo Takahashi; Tomoki Yagai; Taehyeong Kim; Guomin Xie; Hua Wang; Aijuan Qu; Frank J Gonzalez
Journal:  Hepatology       Date:  2019-03-20       Impact factor: 17.425

3.  A transcriptional network signature characterizes lung cancer subtypes.

Authors:  Hsun-Hsien Chang; Jonathan M Dreyfuss; Marco F Ramoni
Journal:  Cancer       Date:  2010-09-13       Impact factor: 6.860

4.  Keratin K6c mutations cause focal palmoplantar keratoderma.

Authors:  Neil J Wilson; Andrew G Messenger; Sancy A Leachman; Edel A O'Toole; E Birgitte Lane; W H Irwin McLean; Frances J D Smith
Journal:  J Invest Dermatol       Date:  2009-07-16       Impact factor: 8.551

Review 5.  N-cadherin signaling in synapse formation and neuronal physiology.

Authors:  Juan L Brusés
Journal:  Mol Neurobiol       Date:  2006-06       Impact factor: 5.682

6.  Matrine reduces the proliferation of A549 cells via the p53/p21/PCNA/eIF4E signaling pathway.

Authors:  Zhiyan Lu; Youzhang Xiao; Xing Liu; Zaipeng Zhang; Feng Xiao; Yongyi Bi
Journal:  Mol Med Rep       Date:  2017-03-16       Impact factor: 2.952

7.  SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma.

Authors:  Yuan Zeng; Dakai Xiao; Huiming He; Jiaxi He; Hui Pan; Wei Yang; Yaoqi Chen; Jianxing He
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

8.  Knockdown of lncRNA MNX1-AS1 suppresses cell proliferation, migration, and invasion in prostate cancer.

Authors:  Zongwu Li; Fangfei Wang; Shibao Zhang
Journal:  FEBS Open Bio       Date:  2019-04-13       Impact factor: 2.693

9.  Placental growth factor promotes epithelial-mesenchymal transition-like changes in ARPE-19 cells under hypoxia.

Authors:  Yi Zhang; Lin Zhao; Lijun Wang; Xiting Yang; Aiyi Zhou; Jianming Wang
Journal:  Mol Vis       Date:  2018-04-26       Impact factor: 2.367

Review 10.  Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.

Authors:  Kentaro Inamura
Journal:  Int J Mol Sci       Date:  2018-04-23       Impact factor: 5.923

View more
  4 in total

1.  Transcript levels of keratin 1/5/6/14/15/16/17 as potential prognostic indicators in melanoma patients.

Authors:  Wei Han; Chan Hu; Zhao-Jun Fan; Guo-Liang Shen
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

2.  Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer.

Authors:  Jiacheng Wu; Haifei Xu; Hao Ji; Baoqian Zhai; Jinfeng Zhu; Mingde Gao; Haixia Zhu; Xiaolin Wang
Journal:  Onco Targets Ther       Date:  2021-01-19       Impact factor: 4.147

3.  Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.

Authors:  Zheqi Liu; Wenkai Zhou; Chengzhong Lin; Xiaoning Wang; Xu Zhang; Yu Zhang; Rong Yang; Wantao Chen; Wei Cao
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

4.  Role of TRPV1 ion channel in cervical squamous cell carcinoma genesis.

Authors:  Zhenming Wang; Junhong Dong; Wenxiu Tian; Sen Qiao; Hongmei Wang
Journal:  Front Mol Biosci       Date:  2022-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.